Literature DB >> 23577628

Human infection with a novel avian-origin influenza A (H7N9) virus.

Rongbao Gao1, Bin Cao, Yunwen Hu, Zijian Feng, Dayan Wang, Wanfu Hu, Jian Chen, Zhijun Jie, Haibo Qiu, Ke Xu, Xuewei Xu, Hongzhou Lu, Wenfei Zhu, Zhancheng Gao, Nijuan Xiang, Yinzhong Shen, Zebao He, Yong Gu, Zhiyong Zhang, Yi Yang, Xiang Zhao, Lei Zhou, Xiaodan Li, Shumei Zou, Ye Zhang, Xiyan Li, Lei Yang, Junfeng Guo, Jie Dong, Qun Li, Libo Dong, Yun Zhu, Tian Bai, Shiwen Wang, Pei Hao, Weizhong Yang, Yanping Zhang, Jun Han, Hongjie Yu, Dexin Li, George F Gao, Guizhen Wu, Yu Wang, Zhenghong Yuan, Yuelong Shu.   

Abstract

BACKGROUND: Infection of poultry with influenza A subtype H7 viruses occurs worldwide, but the introduction of this subtype to humans in Asia has not been observed previously. In March 2013, three urban residents of Shanghai or Anhui, China, presented with rapidly progressing lower respiratory tract infections and were found to be infected with a novel reassortant avian-origin influenza A (H7N9) virus.
METHODS: We obtained and analyzed clinical, epidemiologic, and virologic data from these patients. Respiratory specimens were tested for influenza and other respiratory viruses by means of real-time reverse-transcriptase-polymerase-chain-reaction assays, viral culturing, and sequence analyses.
RESULTS: A novel reassortant avian-origin influenza A (H7N9) virus was isolated from respiratory specimens obtained from all three patients and was identified as H7N9. Sequencing analyses revealed that all the genes from these three viruses were of avian origin, with six internal genes from avian influenza A (H9N2) viruses. Substitution Q226L (H3 numbering) at the 210-loop in the hemagglutinin (HA) gene was found in the A/Anhui/1/2013 and A/Shanghai/2/2013 virus but not in the A/Shanghai/1/2013 virus. A T160A mutation was identified at the 150-loop in the HA gene of all three viruses. A deletion of five amino acids in the neuraminidase (NA) stalk region was found in all three viruses. All three patients presented with fever, cough, and dyspnea. Two of the patients had a history of recent exposure to poultry. Chest radiography revealed diffuse opacities and consolidation. Complications included acute respiratory distress syndrome and multiorgan failure. All three patients died.
CONCLUSIONS: Novel reassortant H7N9 viruses were associated with severe and fatal respiratory disease in three patients. (Funded by the National Basic Research Program of China and others.).

Entities:  

Mesh:

Year:  2013        PMID: 23577628     DOI: 10.1056/NEJMoa1304459

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  1047 in total

1.  Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.

Authors:  Cong Chen; Liguo Liu; Yan Xiao; Sheng Cui; Jianmin Wang; Qi Jin
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

2.  Response profiles of cytokines and chemokines against avian H9N2 influenza virus within the mouse lung.

Authors:  Rong Huang; Jiyuan Liu; Wei Liang; Airong Wang; Zhihao Liu; Yan Yang; Jing Lv; Ying Bao; Yanxia Gao; Zengmin Miao; Tongjie Chai
Journal:  Med Microbiol Immunol       Date:  2013-12-11       Impact factor: 3.402

3.  TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice.

Authors:  Carolin Tarnow; Géraldine Engels; Annika Arendt; Folker Schwalm; Hanna Sediri; Annette Preuss; Peter S Nelson; Wolfgang Garten; Hans-Dieter Klenk; Gülsah Gabriel; Eva Böttcher-Friebertshäuser
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

4.  Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses.

Authors:  Gabriele Neumann; Catherine A Macken; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

5.  Truncation of PA-X Contributes to Virulence and Transmission of H3N8 and H3N2 Canine Influenza Viruses in Dogs.

Authors:  Litao Liu; Shikai Song; Ye Shen; Chao Ma; Tong Wang; Qi Tong; Honglei Sun; Juan Pu; Munir Iqbal; Jinhua Liu; Yipeng Sun
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

6.  Differential diagnosis of respiratory viruses by using real time RT-PCR methodology.

Authors:  Renato de Souza Paulino; Margarete Aparecida Benega; Katia Corrêa de Oliveira Santos; Daniela Bernardes Borges da Silva; Juliana Cristina Pereira; Norio Augusto Sasaki; Patricia Evelin Silva; Suely Pires Curti; Maria Isabel Oliveira; Telma R M P Carvalhanas; Teresa Peret; Dean Erdman; Terezinha Maria de Paiva
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Nov-Dec       Impact factor: 1.846

7.  A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors.

Authors:  Heng Zhang; Robert P de Vries; Netanel Tzarum; Xueyong Zhu; Wenli Yu; Ryan McBride; James C Paulson; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

8.  Dissemination, divergence and establishment of H7N9 influenza viruses in China.

Authors:  Tommy Tsan-Yuk Lam; Boping Zhou; Jia Wang; Yujuan Chai; Yongyi Shen; Xinchun Chen; Chi Ma; Wenshan Hong; Yin Chen; Yanjun Zhang; Lian Duan; Peiwen Chen; Junfei Jiang; Yu Zhang; Lifeng Li; Leo Lit Man Poon; Richard J Webby; David K Smith; Gabriel M Leung; Joseph S M Peiris; Edward C Holmes; Yi Guan; Huachen Zhu
Journal:  Nature       Date:  2015-03-11       Impact factor: 49.962

9.  Clinical comparison of one recovered case and one fatal case of human infection with H7N9 avian influenza in Shanghai Public Health Clinical Center in China.

Authors:  Yufang Zheng; Ye Cao; Yunfei Lu; Xiuhong Xi; Zhiping Qian; Douglas Lowrie; Xinian Liu; Yanbing Wang; Zhang Qi; Shuihua Lu; Hongzhou Lu
Journal:  Malays J Med Sci       Date:  2013-07

10.  Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.

Authors:  Shuofeng Yuan; Naru Zhang; Kailash Singh; Huiping Shuai; Hin Chu; Jie Zhou; Billy K C Chow; Bo-Jian Zheng
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.